Document is current
Any future updates will be listed below
-
Authors
Yang, Guozhen
Su, Xiaodong
Huang, Yuanheng
Luo, Guangyu
Wang, Zhiqiang
Cai, Peiqiang
Zheng, Yating
Bei, Ting
Huang, Mengli
Bai, Yuezong
He, Haoqiang
Xiang, Jin
Cai, Muyan
Zhong, Jiudi
Guo, Qiyu
Zhang, Xu https://orcid.org/0000-0003-0347-8029
-
Funding
Funding for this research was provided by:
the Science and Technology Program of Guangzhou, China (202103000064)
the Science and Technology Project of Guangdong Esophageal Cancer Research Institute (M202017)
- License Information
-
More Information
Article History
Received: 15 March 2023
Accepted: 13 June 2023
First Online: 24 June 2023
Declarations
:
: This study was approved by the institutional review boards at Sun Yat-sen University Cancer Center (B2019-226-01) and all patients provided written informed consents.
: Not applicable.
: Yating Zheng, Ting Bei, Mengli Huang, and Yuezong Bai declare that they are employees of 3D Medicines Inc.
